NIH funding Archive — Page 5 of 8
-
January 10, 2019
Study identifies novel genetic factors for colorectal cancer risk
A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer. -
November 1, 2018
Team’s findings show glutamine metabolism affects T cell signaling
The cellular nutrient glutamine launches a metabolic signaling pathway that promotes the function of some immune system T cells and suppresses others, Vanderbilt researchers have discovered. -
October 11, 2018
Team’s study reveals hidden lives of medical biomarkers
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock? -
September 20, 2018
New HIV research training program launched
With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs. -
September 13, 2018
Study tracks incidence, timing of immunotherapy-related deaths
Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies. -
September 6, 2018
‘Borderline’ lung hypertension should not be ignored: studies
Pulmonary hypertension is a common complication of chronic diseases that occurs when there is increased blood pressure in the arteries carrying blood from the right side of the heart to the lungs. -
August 23, 2018
Enzyme helps build motor that drives neuron death
Vanderbilt scientists have discovered a signaling mechanism that tells neurons to die, findings that could lead to new treatments for neurodegenerative diseases.